Showing results (31-40 of 205) with videos related to
Sort By:
Pageof 21
Trends in Cancer|June 15, 2020
Advanced Prostate Cancer: Treatment Advances and Future DirectionsUmang Swami, Taylor R McFarland, Roberto Nussenzveig, et al.Critical Reviews in Oncology/Hematology|April 16, 2011
Eribulin -- a review of preclinical and clinical studiesUmang Swami, Imran Chaudhary, Mohammad H Ghalib, et al.American Journal of Translational Research|August 11, 2021
Development of PARP inhibitor combinations for castration resistant prostate cancer unselected for homologous recombination repair mutationsTaylor Ryan McFarland, Adam Kessel, Umang Swami, et al.Expert Review of Anticancer Therapy|March 7, 2022
Current and emerging role of sacituzumab govitecan in the management of urothelial carcinomaVinay Mathew Thomas, Nishita Tripathi, Neeraj Agarwal, et al.Expert Review of Anticancer Therapy|July 22, 2022
Relugolix in the management of prostate cancerKamal Kant Sahu, Nishita Tripathi, Neeraj Agarwal, et al.Cancer Management and Research|June 18, 2020
Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular CarcinomaNityam Rathi, Benjamin L Maughan, Neeraj Agarwal, et al.Current Clinical Pharmacology|November 10, 2015
Imatinib Dosing in Gastrointestinal Stromal Tumors (GISTs): When, How Much, and How Long?Mohammed Milhem, Jeremy M DeutschCancer Treatment and Research Communications|October 26, 2021
Emergence of polyclonal BRCA2 reversions following PARP inhibitor treatment: An illustrative case reportTaylor Ryan McFarland, Clara Elizabeth Tandar, Neeraj Agarwal, et al.Life (Basel, Switzerland)|February 24, 2024
PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic LandscapeAshaar Al-Akhras, Chadi Hage Chehade, Arshit Narang, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 10, 2019
Clinical outcomes and toxicities of pazopanib administered orally in crushed form: Case reports and review of the literatureJill Stein, Mohammed Milhem, Daniel VaenaPageof 21